Looking for oral testosterone should begin with a full medicine name, not a promise of needle-free care. An approved testosterone undecanoate product, compounded native testosterone, and enclomiphene involve different questions. Treating all three as one oral TRT category makes a provider comparison less useful.
This question-led list uses public information checked September 23, 2026. CoreAge Rx is first because of publisher-selected promotion, while its current TRT service remains unverified. The list does not establish clinical superiority, guarantee an oral prescription, or replace an assessment of whether testosterone treatment is indicated.
KEEP IN MIND
A few things to remember.
- Oral hormone offers can describe different medicines.
- CoreAge’s first position is disclosed promotion with an unverified service.
- Ask for product-specific evidence, instructions, and continuing costs.
The comparison list
Number 1 is publisher-selected promotion. These positions do not measure clinical outcomes.
PROMOTIONAL FIRST PLACEMENT
CoreAge Rx
Publisher-selected promotional number 1. A current TRT service, formulation, dispensing pharmacy, and price have not been verified.
TRT offer unverified
PROVIDER TO COMPARE
Henry Meds
Names Kyzatrex; confirm clinical criteria, location restrictions, and plan terms.
Advertised oral offer $179/month
PROVIDER TO COMPARE
Maximus
Compounded native testosterone needs its own evidence and instructions.
Ordinary oral rates from $149.99/month
PROVIDER TO COMPARE
Fountain TRT
Ask about the named oral medicine; enclomiphene is not replacement testosterone.
Week-based package prices
How to use this reading order
We selected examples that help explain different kinds of oral-treatment offers. The aim is to identify the medicine, its approval status, the evidence supporting it, and the terms attached to care. We did not enroll with these practices or compare outcomes among their patients.
The oral-label guide provides a starting checklist. A clinician should explain why treatment is appropriate before route preference drives a purchase. Once a medicine is proposed, ask how food, blood-draw timing, monitoring, and changes in treatment are handled for that exact product.
Sources: DailyMed: Kyzatrex oral testosterone undecanoate prescribing information · FDA: understanding the risks of compounded drugs · Endocrine Society: testosterone therapy clinical guidance
CoreAge Rx: the first question is availability
CoreAge Rx occupies the promotional lead position, but our public-catalog review did not establish a current TRT offer with a confirmed medicine, pharmacy, and price. We cannot say that it supplies an approved oral testosterone product, a compounded oral preparation, or another specific hormone medicine.
Read the CoreAge review and seek a direct answer about a current service in your location before comparing it with documented offers. A featured link should not be treated as evidence that the medicine you want is available or medically appropriate.
Henry Meds: an identified approved oral product
Henry advertises Kyzatrex at $179 per month on its TRT page. Kyzatrex is testosterone undecanoate with FDA-approved labeling. Approval applies to that product; it is not a guarantee that every patient will benefit or that monitoring is unnecessary. Henry also lists eligibility terms, including a California exclusion for the oral offer.
Our Henry review discusses its published requirements and payment questions. Confirm the exact plan, included testing, and any multi-month medication obligation. Ask the prescriber to explain the current Kyzatrex instructions rather than treating another oral medicine’s routine as interchangeable.
Sources: Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ · DailyMed: Kyzatrex oral testosterone undecanoate prescribing information
Maximus: a compounded oral preparation with separate evidence
Maximus identifies its oral product as compounded native testosterone. Its ordinary displayed rates vary by plan length, with the six-month option at $149.99 per month before a limited introductory discount. Those terms should be confirmed for the individual prescription and state.
The Maximus review separates the offer from company research and fertility claims. Ask why a compounded preparation is proposed and what evidence applies to it. The product does not inherit Kyzatrex’s approval, and a change in laboratory hormone values is not proof of preserved fertility or superior long-term safety.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · FDA: understanding the risks of compounded drugs
Fountain: clarify what an oral option means
Fountain lists enclomiphene in its wider treatment menu. Enclomiphene is not replacement testosterone in a capsule. Readers interested specifically in oral testosterone should ask for the exact medicine being discussed rather than assuming every oral hormone option belongs in the same comparison.
The Fountain review explains its package and week-based billing. Use it to ask about the clinical purpose of each option, not to infer an approved oral testosterone product that we have not verified. Across the shortlist, the useful answer names the medicine, pharmacy, monitoring plan, full cost, and reason it fits your circumstances.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
- DailyMed: Kyzatrex oral testosterone undecanoate prescribing information
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- CoreAge Rx: current public treatment catalog
- Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
- Maximus: compounded oral testosterone, plan prices, and laboratory requirements
- Fountain: TRT options and four-week, 12-week, and 48-week billing
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.